Ann: MyFiziq to expand technology into cancer care, page-23

JAar

Doesn’t matter how hard you try, your argument about the share price is completely invalid.

The only reason why the SP reached a high of $0.78 prior to December 2017 is because the misleading research report was released on 16 October 2017. Before this date it was trading at around 5 cents.

The revenue projections were not wrong simply due to timing, they are in fact misleading as no other app converts at those rates.

As for the fund manager, if we are talking about ACAM, there is a Facebook page created by a number of Japanese investors who have never got their investment back.